Literature DB >> 23038246

β-Catenin activates the HOXA10 and CDX4 genes in myeloid progenitor cells.

Ling Bei1, Chirag Shah, Hao Wang, Weiqi Huang, Rupali Roy, Elizabeth A Eklund.   

Abstract

HoxA10 is a homeodomain transcription factor that is involved in maintenance of the myeloid progenitor population and implicated in myeloid leukemogenesis. Previously, we found that FGF2 and CDX4 are direct target genes of HoxA10 and that HOXA10 is a Cdx4 target gene. We also found that increased production of fibroblast growth factor 2 (Fgf2) by HoxA10-overexpressing myeloid progenitor cells results in activation of β-catenin in an autocrine manner. In this study, we identify novel cis elements in the CDX4 and HOXA10 genes that are activated by β-catenin in myeloid progenitor cells. We determine that β-catenin interacts with these cis elements, identifying both CDX4 and HOXA10 as β-catenin target genes in this context. We demonstrate that HoxA10-induced CDX4 transcription is influenced by Fgf2-dependent β-catenin activation. Similarly, Cdx4-induced HOXA10 transcription is influenced by β-catenin in an Fgf2-dependent manner. Increased expression of a set of Hox proteins, including HoxA10, is associated with poor prognosis in acute myeloid leukemia. Cdx4 contributes to leukemogenesis in Hox-overexpressing acute myeloid leukemia, and increased β-catenin activity is also associated with poor prognosis. The current studies identify a molecular mechanisms through which increased expression of HoxA10 increases Cdx4 expression by direct CDX4 activation and by Fgf2-induced β-catenin activity. This results in Cdx4-induced HoxA10-expression, creating a positive feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038246      PMCID: PMC3501069          DOI: 10.1074/jbc.M112.402172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo.

Authors:  C Buske; M Feuring-Buske; J Antonchuk; P Rosten; D E Hogge; C J Eaves; R K Humphries
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

2.  rVista for comparative sequence-based discovery of functional transcription factor binding sites.

Authors:  Gabriela G Loots; Ivan Ovcharenko; Lior Pachter; Inna Dubchak; Edward M Rubin
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

3.  Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins.

Authors:  Matthew J Oberley; Peggy J Farnham
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

4.  Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.

Authors:  Unnur Thorsteinsdottir; Aline Mamo; Evert Kroon; Lori Jerome; Janet Bijl; H Jeffrey Lawrence; Keith Humphries; Guy Sauvageau
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  VISTA : visualizing global DNA sequence alignments of arbitrary length.

Authors:  C Mayor; M Brudno; J R Schwartz; A Poliakov; E M Rubin; K A Frazer; L S Pachter; I Dubchak
Journal:  Bioinformatics       Date:  2000-11       Impact factor: 6.937

6.  Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10.

Authors:  J M Björnsson; E Andersson; P Lundström; N Larsson; X Xu; E Repetowska; R K Humphries; S Karlsson
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

7.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Authors:  Scott A Armstrong; Jane E Staunton; Lewis B Silverman; Rob Pieters; Monique L den Boer; Mark D Minden; Stephen E Sallan; Eric S Lander; Todd R Golub; Stanley J Korsmeyer
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

8.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

10.  cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes.

Authors:  Alan J Davidson; Patricia Ernst; Yuan Wang; Marcus P S Dekens; Paul D Kingsley; James Palis; Stanley J Korsmeyer; George Q Daley; Leonard I Zon
Journal:  Nature       Date:  2003-09-18       Impact factor: 49.962

View more
  9 in total

1.  HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.

Authors:  Qingyu Yang; Qi Zhang; Xuewu Zhang; Lei You; Wenbiao Wang; Weiyong Liu; Yang Han; Chunqiang Ma; Wei Xu; Junbo Chen; Hua Yang; Pin Wan; Yao Zhou; Yingle Liu; Kailang Wu; Ziwen Yang; Jianguo Wu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

2.  HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma.

Authors:  Manoela Carrera; Carolina C Bitu; Carine Ervolino de Oliveira; Nilva K Cervigne; Edgard Graner; Aki Manninen; Tuula Salo; Ricardo D Coletta
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.

Authors:  Chirag A Shah; Ling Bei; Hao Wang; Leonidas C Platanias; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

4.  Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis.

Authors:  Guodong Wang; Jian Liu; Yi Cai; Jie Chen; Wenbing Xie; Xiangqian Kong; Wenjie Huang; Hao Guo; Xiaodi Zhao; Yuanyuan Lu; Lu Niu; Xiaowei Li; Haijia Zhang; Chao Lei; Zhijie Lei; Jipeng Yin; Hao Hu; Fan Yu; Yongzhan Nie; Limin Xia; Kaichun Wu
Journal:  Oncotarget       Date:  2017-05-30

5.  Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML.

Authors:  Hamid Sayar; Yan Liu; Rui Gao; Mohammad Abu Zaid; Larry D Cripe; Jill Weisenbach; Katie J Sargent; Mehdi Nassiri; Lang Li; Heiko Konig; Attaya Suvannasankha; Feng Pan; Rajasubramaniam Shanmugam; Chirayu Goswami; Reuben Kapur; Mingjiang Xu; H Scott Boswell
Journal:  Oncotarget       Date:  2017-12-25

6.  Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes.

Authors:  Yushuai Mi; Senlin Zhao; Chongzhi Zhou; Junyong Weng; Jikun Li; Zhanshan Wang; Huimin Sun; Huamei Tang; Xin Zhang; Xiaofeng Sun; Zhihai Peng; Yugang Wen
Journal:  Oncotarget       Date:  2016-09-13

7.  LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.

Authors:  Ming Shao; Qiankun Yang; Weitao Zhu; Huifang Jin; Jing Wang; Jie Song; Yongkui Kong; Xianping Lv
Journal:  Mol Cancer       Date:  2018-12-13       Impact factor: 27.401

8.  Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.

Authors:  Chirag A Shah; Ling Bei; Hao Wang; Jessica K Altman; Leonidas C Platanias; Elizabeth A Eklund
Journal:  Oncotarget       Date:  2016-08-23

9.  An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in MLL1-rearranged acute myeloid leukemia in mice.

Authors:  Hao Wang; Chirag A Shah; Liping Hu; Weiqi Huang; Leonidas C Platanias; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2020-05-28       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.